Jefferies believes aggressive moves by incumbents and entry of new players in the QC space can result in higher discounting ...
Jefferies has made some changes to its well-respected Franchise Picks list. Three of its picks for 2025 look like outstanding ...
Jefferies analyst Daniel Fannon maintained a Buy rating on Goldman Sachs Group (GS – Research Report) today and set a price target of $667.00.
Topgolf Callaway stock rose Thursday after Jefferies analysts raised their rating on shares of the golf equipment ...
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions ...
Jefferies analyst Julien Dumoulin Smith reiterated a Buy rating on GE Vernova Inc. (GEV – Research Report) yesterday and set a price target of ...
The downgrades come amid a broader recalibration across the consumer goods sector. Jefferies analysts described 2025 as a pivotal year, with the industry expected to emerge from what they termed a ...
The yield on 10-year Bunds edged up and Jefferies said it had a buy level at 2.40%, so would prefer “a long position at [the] current level.” ...
The outlook for India's auto industry in 2025 shows signs of divergence in growth among key sectors, with two-wheelers and ...
RIL's current valuation is at its lowest since the COVID-19 market shock of March 2020. However, the stock lagged behind the ...
The Wall Street Journal on MSN1d
Credit Is Worth Buying Again, Jefferies Says
Attractive total yields and much cleaner positioning are among the reasons investors should consider reinstating long positions in credit, Jefferies said.
Key stocks recommended by Jefferies for 2025 include Mankind Pharma, JB Chemicals, and Sun Pharmaceutical Industries.